S&P 500
(0.53%) 5 044.96 points
Dow Jones
(0.54%) 38 109 points
Nasdaq
(0.97%) 15 756 points
Oil
(0.23%) $79.18
Gas
(5.33%) $2.04
Gold
(-0.06%) $2 309.60
Silver
(0.34%) $26.84
Platinum
(0.95%) $964.00
USD/EUR
(0.01%) $0.933
USD/NOK
(-0.19%) $11.01
USD/GBP
(0.04%) $0.799
USD/RUB
(-1.36%) $92.00

Realaus laiko atnaujinimai ETFMG Treatments, Testing [GERM]

Birža: NYSE
Atnaujinta2 geg. 2024 @ 17:36

0.81% $ 17.87

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 17:36):
Profile picture for ETFMG Treatments, Testing and Advancements ETF

The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients...

Stats
Šios dienos apimtis 676.00
Vidutinė apimtis 2 001.00
Rinkos kapitalizacija 11.48M
Last Dividend $0.0400 ( 2023-09-20 )
Next Dividend $0 ( N/A )
P/E 6.95
ATR14 $0 (0.00%)

ETFMG Treatments, Testing Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
SBSW0.907
D0.895
PDS0.895
WRK0.89
DHX0.889
BKH0.876
PHX0.869
TSN0.868
ATTO0.868
HBI0.867
10 Labiausiai neigiamai susiję koreliacijos
COR-0.914
TNK-0.905
GHM-0.866
CSLT-0.861
NWHM-0.86
BBL-0.85
DVD-0.847
MOG-B-0.838
AMAM-0.836
TK-0.836

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Financial Reports:

No articles found.

ETFMG Treatments, Testing Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0600
(N/A)
$0.0286
(N/A)
$0.0900
(N/A)
$0.0600
(N/A)
$0.0400
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

ETFMG Treatments, Testing Dividend Information - Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.285 2020-12-14
Last Dividend $0.0400 2023-09-20
Next Dividend $0 N/A
Payout Date 2023-09-22
Next Payout Date N/A
# dividends 10 --
Total Paid Out $0.715 --
Avg. Dividend % Per Year 0.42% --
Score 1.27 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-06-19)
$0.0358 Estimate 19.62 %
Dividend Stability
0.52 Average
Dividend Score
1.27
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
2020 $0.285 1.13%
2021 $0.101 0.32%
2022 $0.139 0.39%
2023 $0.190 0.85%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
ORC Dividend Royal 2023-11-29 Monthly 12 9.23% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM01.500-1.111-1.667[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM02.0000[0 - 30]
freeCashFlowPerShareTTM02.0000[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score-2.53

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM01.000-0.1010[1 - 100]
returnOnEquityTTM02.50-0.714-1.667[0.1 - 1.5]
freeCashFlowPerShareTTM02.0000[0 - 30]
dividendYielPercentageTTM2.891.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM02.0000[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score0.561

ETFMG Treatments, Testing

The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.